To direct the Attorney General and the Secretary of Health and Human Services to evaluate the effectiveness of grant programs that provide grants for the primary purpose of providing assistance in addressing problems pertaining to opioid abuse, and for other purposes.
The bill’s titles are written by its sponsor.
Apr 26, 2016
Passed House on May 10, 2016
This bill passed in the House on May 10, 2016 and goes to the Senate next for consideration.
Representative for California's 23rd congressional district
Read Text »
Last Updated: May 11, 2016
Length: 7 pages
H.R. 5052 is a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2016). H.R. 5052 — 114th Congress: OPEN Act. Retrieved from https://www.govtrack.us/congress/bills/114/hr5052
“H.R. 5052 — 114th Congress: OPEN Act.” www.GovTrack.us. 2016. October 24, 2016 <https://www.govtrack.us/congress/bills/114/hr5052>
|title=H.R. 5052 (114th)
|accessdate=October 24, 2016
|author=114th Congress (2016)
|date=April 26, 2016
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.